No Data
No Data
No Data
No Data
No Data
Opthea Announces Upcoming Presentations at the Retina World Congress 2024
MELBOURNE, Australia and PRINCETON, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT, the "Company")), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent
GlobeNewswireMay 1 19:30
Opthea Showcases Retinal Disease Therapy Advances
TipRanksMay 1 09:57
Opthea Advances Pivotal Trials for Eye Disease Drug
TipRanksApr 30 07:57
Opthea to Present at the OIS Retina Innovation Summit at ARVO
MELBOURNE, Australia and PRINCETON, N.J., April 25, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT, the "Company")), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent
GlobeNewswireApr 25 21:00
Opthea Limited Issues New Contractor Options
TipRanksApr 15 11:17
Owning 39% Shares,institutional Owners Seem Interested in Opthea Limited (ASX:OPT),
Yahoo FinanceApr 13 04:49
No Data
No Data